Global Blood Warmer Devices Market Overview:
Blood or fluids are heated in a Blood/Solution Warmer before being transfused into a patient. A blood warmer is used when there are concerns about transfusing a large volume of cold fluids. This may be necessary in cases where patients have been severely injured and require large transfusions, or when they are medically frail. A blood warmer, will not provide substantial benefits once a patient's body has begun to cool it is intended to prevent heat loss. Blood warmer devices are used in a variety of healthcare settings to warm crystalloids, fluids, or blood products, as well as to prevent hypothermia in surgical or physically traumatised patients. Before moving fluids or blood to a patient, the fluids or blood must be warmed. Fluid warmers are commonly used in ICUs (Intensive Care Units), emergency rooms, and operating rooms to prevent the condition of hypothermia. Automatic temperature adjustments, flow rate adjustments, and an alarm system are just a few of the features available in blood warmers.
- Increasing Hypothermia Cases
- Increasing Number of Surgeries
- Advancement in the Existing Products
- Various Other Alternatives Available
- Increasing Investment in the Healthcare Industry
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are 3M (United States), Smiths Medical (United States), BD (United States), The 37Company (Netherlands), Geratherm Medical (Germany), Stryker (United States), Sarstedt (Germany), Barkey (Germany), Stihler Electronic (Germany), Belmont Instrument (United States), Biegler (Austria) and EMIT (United States). Additionally, following companies can also be profiled that are part of our coverage like Vyaire Medical inc (United States) and Combat medical (United States). Analyst at AMA Research see Germany Players to retain maximum share of Global Blood Warmer Devices market by 2026. Considering Market by End-Use, the sub-segment i.e. Hospitals will boost the Blood Warmer Devices market.
Protocol for the use of blood and fluid warmers should be establishes in organisation policies and procedures and in accordance with AABB standards for administration for blood and The Medicines and Healthcare products Regulatory Agency (MHRA) is an arms‐length government organisation responsible for overseeing the regulation of medical devices used in the UK.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Blood Warmer Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Blood Warmer Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Blood Warmer Devices, Suppliers of Blood Warmer Devices, Wholesalers, Distributors and Retailers of Blood Warmer Devices, Healthcare Industry, Government Institutions, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.